Upstream Bio (UPB) Income Statement: Revenue & Earnings

Upstream Bio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Upstream Bio, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Revenue & Gross Profit
Revenue	2.37	2.38	1.21
Cost of Revenue	0.00	0.00	0.00
Gross Profit	2.37	2.38	1.21
Operating Expenses
Research & Development	62.97	31.80	18.66
Selling, General & Administrative	17.17	10.70	6.46
Operating Expenses	80.13	42.49	25.12
Operating Income	-77.76	-40.11	-23.91
Other Income/Expense
Interest Income	12.12	4.17	0.21
Interest Expense	0.00	0.00	0.00
Other Income/Expense	2.84	15.41	-0.16
Income
Income Before Tax	-62.81	-20.54	-23.87
Income Tax Expense	0.00	0.00	0.00
Net Income	-62.81	-20.54	-23.87
Net Income - Continuous Operations	-62.81	-20.54	-23.87
Net Income - Discontinued Operations	0.00	0.00	0.00
EBITDA	-77.68	-40.05	-23.90
EBIT	-77.76	-40.11	-23.91
Depreciation & Amortization	0.09	0.06	0.01
Earnings Per Share
Basic EPS	-1.00	-1.00	-1.00
Diluted EPS	-1.00	-1.00	-1.00
Basic Shares Outstanding	53.60	36.32	36.32
Diluted Shares Outstanding	53.60	36.32	36.32